Nissay Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Buy |
23,713
+1,056
| +5% | +$592K | 0.05% | 222 |
|
|
2026
Q1 | $12.7M | Buy |
22,657
+641
| +3% | +$411K | 0.07% | 188 |
|
|
2025
Q4 | $14.9M | Buy |
22,016
+1,032
| +5% | +$703K | 0.08% | 167 |
|
|
2025
Q3 | $13.4M | Buy |
20,984
+206
| +1% | +$125K | 0.07% | 177 |
|
|
2025
Q2 | $11.1M | Buy |
20,778
+389
| +2% | +$186K | 0.07% | 203 |
|
|
2025
Q1 | $8.56M | Buy |
20,389
+1,701
| +9% | +$739K | 0.06% | 226 |
|
|
2024
Q4 | $7.75M | Buy |
18,688
+698
| +4% | +$306K | 0.05% | 246 |
|
|
2024
Q3 | $9.09M | Buy |
17,990
+1,360
| +8% | +$661K | 0.06% | 216 |
|
|
2024
Q2 | $8.1M | Buy |
16,630
+1,821
| +12% | +$914K | 0.05% | 219 |
|
|
2024
Q1 | $8M | Buy |
14,809
+3,473
| +31% | +$1.9M | 0.06% | 208 |
|
|
2023
Q4 | $6.29M | Buy |
11,336
+391
| +4% | +$184K | 0.05% | 216 |
|
|
2023
Q3 | $4.79M | Buy |
10,945
+696
| +7% | +$347K | 0.04% | 242 |
|
|
2023
Q2 | $5.15M | Buy |
10,249
+137
| +1% | +$65.7K | 0.04% | 229 |
|
|
2023
Q1 | $5.06M | Sell |
10,112
-308
| -3% | -$147K | 0.05% | 231 |
|
|
2022
Q4 | $4.25M | Sell |
10,420
-420
| -4% | -$163K | 0.04% | 263 |
|
|
2022
Q3 | $3.53M | Buy |
10,840
+278
| +3% | +$102K | 0.04% | 286 |
|
|
2022
Q2 | $3.7M | Sell |
10,562
-340
| -3% | -$139K | 0.04% | 269 |
|
|
2022
Q1 | $5.96M | Buy |
10,902
+181
| +2% | +$95.2K | 0.05% | 215 |
|
|
2021
Q4 | $7.06M | Buy |
10,721
+221
| +2% | +$139K | 0.05% | 200 |
|
|
2021
Q3 | $6.53M | Buy |
10,500
+280
| +3% | +$188K | 0.06% | 194 |
|
|
2021
Q2 | $6.45M | Buy |
10,220
+1,146
| +13% | +$633K | 0.06% | 198 |
|
|
2021
Q1 | $4.44M | Sell |
9,074
-194
| -2% | -$97.2K | 0.04% | 243 |
|
|
2020
Q4 | $4.63M | Buy |
9,268
+247
| +3% | +$111K | 0.07% | 209 |
|
|
2020
Q3 | $3.55M | Sell |
9,021
-2,543
| -22% | -$940K | 0.06% | 230 |
|
|
2020
Q2 | $3.82M | Sell |
11,564
-1,873
| -14% | -$542K | 0.07% | 235 |
|
|
2020
Q1 | $3.25M | Buy |
13,437
+182
| +1% | +$47.5K | 0.08% | 223 |
|
|
2019
Q4 | $3.46M | Buy |
13,255
+1,101
| +9% | +$290K | 0.08% | 273 |
|
|
2019
Q3 | $3.31M | Buy |
12,154
+409
| +3% | +$114K | 0.08% | 280 |
|
|
2019
Q2 | $3.23M | Sell |
11,745
-891
| -7% | -$220K | 0.08% | 271 |
|
|
2019
Q1 | $2.83M | Sell |
12,636
-892
| -7% | -$184K | 0.07% | 306 |
|
|
2018
Q4 | $2.52M | Buy |
13,528
+631
| +5% | +$129K | 0.08% | 303 |
|
|
2018
Q3 | $3.22M | Buy |
12,897
+138
| +1% | +$33.5K | 0.09% | 272 |
|
|
2018
Q2 | $2.78M | Buy |
12,759
+6,873
| +117% | +$1.42M | 0.08% | 302 |
|
|
2018
Q1 | $1.13M | Buy |
5,886
+66
| +1% | +$12.2K | 0.04% | 406 |
|
|
2017
Q4 | $910K | Buy |
+5,820
| New | +$916K | 0.03% | 460 |
|
Other funds holding IDXX
Nissay Asset Management's IDXX Position: Q2 2026 in Review
Nissay Asset Management increased its Idexx Laboratories (IDXX) stake by 4.7% in Q2 2026, buying an estimated $592K and bringing the position to 23,713 shares worth $12.5M. The position accounts for 0.05% of the portfolio, ranked #222.
Nissay Asset Management first reported a position in IDXX in Q4 2017 and has held it in 35 quarters since. The position peaked at $14.9M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Nissay Asset Management held 23,713 shares of Idexx Laboratories worth $12.5M as of Q2 2026.
- Nissay Asset Management bought 1,056 Idexx Laboratories shares in Q2 2026, an estimated $592K.
- Idexx Laboratories made up 0.05% of Nissay Asset Management's portfolio in Q2 2026, its #222 holding.
- Nissay Asset Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's Idexx Laboratories position peaked at $14.9M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.